seed
Stage
1
Investors
About
Oncomedics develops diagnostic tests that predict patient response to anti-tumor therapies, aiming to tailor cancer treatments for improved effectiveness.
Explore Oncomedics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.